Bioblast Pharma Ltd.

Available to platforms

Bioblast Pharma Ltd. (Ticker: ORPN) was a biopharmaceutical company focused on developing treatments for rare and ultra-rare genetic diseases. The company's lead product candidate, Trehalose, was investigated for its potential to treat conditions such as oculopharyngeal muscular dystrophy (OPMD) and spinocerebellar ataxia. Following challenges in its clinical development, Bioblast ceased operations, and its stock was delisted.

Bioblast Pharma Ltd. - ORPN stocks live chart

Analyze price movements of Bioblast Pharma Ltd. online with R StocksTrader stock charts. You don't need to refresh chart as the quotes are updated automatically. View the current and previous ORPN quotes, get all necessary information for adding Bioblast Pharma Ltd. to your investment portfolio.

You can invest in Bioblast Pharma Ltd. and real stocks and CFDs on stocks of other American and European companies in R StocksTrader. Stocks, Indices, Metals: 12,000 assets in total are available for trading in the web terminal. Explore price movements of popular assets, like Bioblast Pharma Ltd., in our "Charts" section and expand your trading opportunities by investing in new instruments.

Risk Warning: past performance of ORPN does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for Bioblast Pharma Ltd. (ORPN).

You can trade Bioblast Pharma Ltd. (ORPN) on the R StocksTrader platform.

You can trade online Bioblast Pharma Ltd. (ORPN) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts